The INFO Project

Johns Hopkins Bloomberg School of Public Health
Español Français Português Population Reports Home Related Resources Contact Us FAQs Site Map Feedback About Population Reports Online Reports Upcoming Reports Press Releases Order
Population Reports Search Population Reports: 
[Or Search POPLINE & other INFOforhealth.org resources]

K Series
Series K, Number 7
Injectables and Implants

Implants: The Next Generation

How family planning programs and providers can prepare to provide new contraceptive implants

CONTENTS

Home (Key Points)

New Implants Can Expand Access
 Table 1. Comparing Implants
Table 2. Continuation Rates for New Implants
Table 3. Estimated Worldwide Use of Implants

Box: Which New Implant to Introduce?

Spotlight: From Norplant to Jadelle: Smooth Transition in a Dominican Republic Clinic

Preparing to Offer New Implants

Spotlight: Training Nurses Increases Implant Use in Ghana

Box: Information and Communication Technology Supports Implant Programs

Meeting Demand for New Implants Requires Supply and Access
 Table 4. Key Resources for Program Managers and Providers of Implants

Bibliography

Credits

From INFO's Toolbox
Box: What Clients Should Know  About Insertion and Removal
INFO Reports: “Implants: Tools for  Providers”

Quick Look
Table 1: Comparing Implants
Table 4: Key Resources for  Program Managers and Providers of Implants

OrderOrder this report
DownloadDownload PDF or PowerPoint
E-mailE-mail this page
See More Population ReportsSee Companion INFO Report
 "Implants: Tools for Providers"
See More Population ReportsSee more Population Reports
See Implants ToolkitSee Implants Toolkit

SPOTLIGHT
From Norplant to Jadelle: Smooth Transition in a Dominican Republic Clinic

PROFAMILIA, a private nonprofit clinic in Santo Domingo, Dominican Republic, had been routinely providing Norplant for 30 years when it successfully switched to Jadelle in 2002. The clinic was eager to start providing the new implant because Jadelle is quicker to insert and remove than Norplant, has fewer complications with removal, and is less visible in the arm.

During the transition researchers studied the acceptability of Jadelle to clients and providers. The clinic offered both Norplant and Jadelle to all clients at the same subsidized price of about US$30. The clinic’s staff learned to provide Jadelle quickly and easily. Initially, some clients were hesitant to use an unfamiliar product. PROFAMILIA has now stopped offering Norplant, however, and its clients are satisfied with Jadelle as an alternative.

The study findings suggest that, especially where Norplant is well-known and liked, counseling clients about the comparative advantages of the new implants is necessary. This counseling led some women to choose Jadelle. Others, however, still preferred Norplant, while it was available. Once PROFAMILIA stopped offering Norplant, counseling was very effective in helping Norplant-seeking clients accept Jadelle.

Providers Adapted Quickly and Overwhelmingly Preferred Jadelle

Because the PROFAMILIA providers were familiar with Norplant, they needed little training to start offering Jadelle. The staff members attended a one-hour training followed by a question and answer session conducted by one of the researchers. The researcher discussed the two implants in terms of effectiveness, adverse events, continuation and termination rates, mechanism of action, and hormone levels in the blood. The researcher also explained insertion and removal procedures but did not perform either a live demonstration or use a model arm.

The majority of the providers were satisfied with this training. One-third would have liked an actual demonstration of insertion and removal as well. Still, none of the providers felt that the lack of a demonstration limited their ability to insert the new implants. A clinic supervisor reported that the staff became comfortable with Jadelle “immediately.”

After providing the new implant for 18 months, the providers almost unanimously preferred Jadelle over Norplant. They favored Jadelle because fewer rods made insertion and removal easier.

Some Clients Hesitant to Choose an Unfamiliar Product

At the PROFAMILIA clinic some women were more comfortable with the method that was well-known and recommended by friends and family, even when an alternative was available. Since there had been little local promotion of Jadelle, most women were unfamiliar with it. Providers explained to clients that inserting and removing Jadelle is quicker, but that Jadelle needs to be replaced after five years, while studies have shown that Norplant is effective for seven years. After hearing this information as well as receiving it on a printed sheet, each client chose the implant that she preferred. Nearly half of the clients chose Norplant. The most common reason cited for this choice was that Norplant had been recommended by a friend, relative, or provider. More than 40% of the women who chose Norplant mentioned that it is better known. Another 15% mentioned that it is registered in the country. Less than 15% said they preferred Norplant because it lasts longer, which is in fact its only potential clinical advantage over Jadelle.

Slightly more than half of the clients chose Jadelle. Their most common reason was the fewer number of rods, followed by easier insertion and removal and less visibility in the arm.

Because almost half of the clients chose Norplant, the researchers initially concluded that providers should continue to offer it while making the transition to Jadelle. While this might ensure that women are comfortable with their contraceptive options, recent experience suggests that it may not be necessary. PROFAMILIA no longer offers Norplant. When clients request it, the provider explains the differences between Jadelle and Norplant and says that Norplant is no longer available. A clinic supervisor noted that virtually all clients accept Jadelle after receiving this counseling rather than choosing a different contraceptive method or declining contraception altogether.

Counseling alone will not persuade every client to choose an unfamiliar product, but it is important to give women complete and comparative information. Inadequate counseling may cause women to avoid a new product for the wrong reason. For example, nearly 9% of those who preferred Norplant chose it for the greater number of capsules, incorrectly reasoning that the additional capsules make it more effective. Thorough, clear counseling on the characteristics of new implants is essential to avoid such misperceptions and to help women make well-informed choices.

Sources: Brache, 2007 (11); Brache, 2006 (12)


Previous | Next
Back to top

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.